Investors Flock to GMO’s New Quality ETF
GMO’s Hancock discusses the firm’s foray into ETFs.
GMO has a long, storied history in the asset management space. A few months ago, the firm began writing a new chapter with the launch of its first exchange-traded fund, the GMO U.S Quality ETF (QLTY).
In this episode of Exchange Traded Fridays, Tom Hancock, partner at GMO, sits down with etf.com senior analyst Sumit Roy and etf.com wealth management editor Jeff Benjamin to discuss QLTY, as well as what other plans GMO has in the ETF space.
QLTY is an actively managed fund that seeks to “enhance returns and mitigate risk by combining a focus on valuation with a powerful blend of quantitative discipline and fundamental analysis.”
Investors have taken notice. In less than three months on the market, QLTY has pulled in nearly a quarter of a billion in assets, an impressive sum for an inaugural ETF.
But what differentiates QLTY from the behemoth in the ETF space, the iShares MSCI USA Quality Factor ETF (QUAL), which has nearly $40 billion in AUM?
Find out in this week’s episode of Exchange Traded Fridays.
